---
figid: PMC9420645__MI2022-7924199.001
figtitle: 'Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer''s Disease'
organisms:
- Saccharomyces cerevisiae
- Glycine max
- herbal medicine
- Curcuma longa
- Eucommia ulmoides
- Zanthoxylum bungeanum
- Stephania tetrandra
- Orthosiphon stamineus
- Uncaria sinensis
- Lactococcus lactis
- Lacticaseibacillus casei
- Lactobacillus acidophilus
- Bifidobacterium bifidum
- Lacticaseibacillus casei str. Zhang
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- gut metagenome
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC9420645
filename: MI2022-7924199.001.jpg
figlink: /pmc/articles/PMC9420645/figure/fig1/
number: F1
caption: TLR4 binds to ligands and activates downstream pathways in both MyD88-dependent
  and MyD88-independent pathways. TLR4-MD2 recruits TIRAP and MyD88 and then signals
  to IRAKs. Then recruit TRAF-6, which with Ubc13 and Uev1A initiate the complex consisting
  of TAK1, TAB1, and TAB2/3 activation. The complexes of IKK-α, IKK-β, and IKK-γ are
  activated, promoting NF-κB entry into the nucleus and leading to the release of
  proinflammatory factors, such as TNF-α, IL-1β, and IL-6. In addition, MAPKs are
  activated, and MAPKs-induced p38, ERK and JNK lead to AP-1 nuclear translocation.
  SOCS1 inhibits the TLR4 signaling pathway by affecting NF-κB, MAPK activity, and
  p65 phosphorylation. TLR4-MD2 leads to endosome formation, resulting in TRAM translocation
  into the cytoplasm and activation of the TRIF-dependent signaling pathway. TRIF
  activates TRAF3 and the TBK1/IKKi complex, leading to phosphorylation of the interferon
  regulatory factors IRF3 and IRF7, which induce type I IFN gene expressions, such
  as IFNα and IFNβ. Besides, TRIF interacts with RIP1, which activates the TAK1 complex
  and NF-κB (this figure is made using the Figdraw).
papertitle: 'Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer''s
  Disease.'
reftext: Linyu Wu, et al. Mediators Inflamm. 2022;2022:7924199.
year: '2022'
doi: 10.1155/2022/7924199
journal_title: Mediators of Inflammation
journal_nlm_ta: Mediators Inflamm
publisher_name: Hindawi
keywords: ''
automl_pathway: 0.957242
figid_alias: PMC9420645__F1
figtype: Figure
redirect_from: /figures/PMC9420645__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9420645__MI2022-7924199.001.html
  '@type': Dataset
  description: TLR4 binds to ligands and activates downstream pathways in both MyD88-dependent
    and MyD88-independent pathways. TLR4-MD2 recruits TIRAP and MyD88 and then signals
    to IRAKs. Then recruit TRAF-6, which with Ubc13 and Uev1A initiate the complex
    consisting of TAK1, TAB1, and TAB2/3 activation. The complexes of IKK-α, IKK-β,
    and IKK-γ are activated, promoting NF-κB entry into the nucleus and leading to
    the release of proinflammatory factors, such as TNF-α, IL-1β, and IL-6. In addition,
    MAPKs are activated, and MAPKs-induced p38, ERK and JNK lead to AP-1 nuclear translocation.
    SOCS1 inhibits the TLR4 signaling pathway by affecting NF-κB, MAPK activity, and
    p65 phosphorylation. TLR4-MD2 leads to endosome formation, resulting in TRAM translocation
    into the cytoplasm and activation of the TRIF-dependent signaling pathway. TRIF
    activates TRAF3 and the TBK1/IKKi complex, leading to phosphorylation of the interferon
    regulatory factors IRF3 and IRF7, which induce type I IFN gene expressions, such
    as IFNα and IFNβ. Besides, TRIF interacts with RIP1, which activates the TAK1
    complex and NF-κB (this figure is made using the Figdraw).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tirap
  - Chuk
  - Ly96
  - Traf6
  - Tlr4
  - Myd88
  - Nfkbib
  - Rela
  - Gorasp1
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Ube2n
  - Tab2
  - Tab3
  - Jun
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Tnf
  - Il18
  - Il6
  - Ephb2
  - Mapk1
  - Irf3
  - Irf7
  - Rnf138
  - Trim69
  - Ticam1
  - Ticam2
  - Mapk8
  - Tmed7
  - Ifna
  - Traf3
  - Ikbke
  - Syt1
  - Ephb1
  - TIRAP
  - CHUK
  - LY96
  - TRAF6
  - TLR4
  - MYD88
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - UBE2N
  - NFKB1
  - UBE2V1
  - TAB2
  - TAB3
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - TNF
  - IL18
  - IL6
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - IRF3
  - IRF7
  - TRIM69
  - TICAM1
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - IFNA1
  - IFN1@
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - TRAF3
  - IKBKE
  - Toll-4
  - dl
  - wash
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - ben
  - Dif
  - Rel
  - Uev1A
  - AP-1gamma
  - Jra
  - kay
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - egr
  - MKP-4
  - rl
  - Erk7
  - bsk
  - TRAM
  - Traf-like
  - tirap
  - traf6
  - myd88
  - rela
  - nfkb1
  - tab2
  - tab3
  - mapk14a
  - tnfb
  - il6
  - irf3
  - irf7
  - ticam1
  - mapk8b
  - tram1
  - ifnphi1
  - traf3
---
